HIV type 2 Envelope protein, recombinant protein from E. coli
Recombinant Human immunodeficiency virus-II Envelope
Immunoreactive with all sera of HIV-2 infected individuals.
Greater than 95.0% as determined by HPLC analysis and SDS-PAGE.
Sterile filtered colorless clear solution. 50 mM Tris-HCL + 6M urea, pH-7.
2-8°C short term, -20°C long term
HIV-2 Envelope recombinantcomposes all of the reported immunogenic determinants found in gp39. The gene encoding this fusion protein was synthesized using codons optimized for E. coli expression and doesn't represent a linear HIV-2 envelope sequence.
Many viruses (e.g. influenza and many animal viruses) have viral envelopes covering their protein capsids. The envelopes typically are derived from portions of the host cell membranes (phospholipids and proteins), but include some viral glycoproteins. Fun
Envelope glycoprotein gp160; Glycoprotein 120; Glycoprotein 41; gp120; gp4; HIV-2 Envelope; HIV2 Envelope; Human Immunodeficiency Virus Type 2 Envelope